Test Price
2,800 AED✅ Home Collection Available
NOTCH1 Gene Aortic Valve Disease Type 1 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Gold-standard, DHA-compliant next-generation sequencing for NOTCH1-related aortic valve disease. This definitive genetic analysis delivers full coding and splice-site coverage with 99.9% diagnostic sensitivity, enabling precise risk stratification, family screening, and pre-surgical planning.
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- ✔ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- ✔ Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by a DHA-licensed physician.
- ✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The NOTCH1 NGS test is a definitive genetic analysis for Aortic Valve Disease type 1 (AOVD1), confirming pathogenic variants in the NOTCH1 gene – essential for risk stratification, family screening, and surgical planning. The assay employs next-generation sequencing with orthogonal Sanger validation to ensure variant-level accuracy exceeding 99.9% across all coding exons and flanking splice junctions.
| Feature | Our Test (NOTCH1 NGS) | Closest Alternative |
|---|---|---|
| Precision | Full coding & splice‑site coverage; variant detection ≥99.9% | Limited to known hot‑spots; may miss novel mutations |
| Method | Next‑Generation Sequencing (NGS) with Sanger validation | Sanger sequencing of selected exons |
| Speed | 3–4 Weeks | 5–6 Weeks (if multiple exons tested individually) |
| Clinical Interpretation | Board‑certified geneticist + cardiologist review | Automated variant calling, limited counseling |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I recognize the profound implications of NOTCH1 testing for patients and their families. This analysis delivers objective, actionable information to guide cardiovascular care and family planning, but it must be interpreted alongside echocardiographic findings and complete clinical history for accurate risk assessment.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
⚠ Medication Advisory
Continue all prescribed medications including anticoagulants and antihypertensives unless explicitly instructed otherwise by your treating physician. Abrupt discontinuation may increase cardiovascular risk.
Safety Exclusion & Red Flags
- Exclusion Criteria: Not suitable for patients experiencing acute myocardial infarction, decompensated heart failure, or those unable to give informed consent.
- Emergency Red Flags: New‑onset crushing chest pain, fainting (syncope), severe shortness of breath, or palpitations – seek immediate emergency room care.
- Pediatric Notice: For minors, testing is conducted only with legal guardian consent and in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does the NOTCH1 gene test detect?
The NOTCH1 Genetic Test comprehensively sequences the entire coding region and splice sites of the NOTCH1 gene to detect pathogenic variants linked to Aortic Valve Disease type 1. This enables precise diagnosis, identification of at‑risk family members, and preoperative risk stratification.
2. How is the sample collected and how long until results?
A trained phlebotomist collects a single blood sample at your home or office using ISO-certified cold-chain protocols under our VIP Mobile Phlebotomy service. Results are available in 3–4 weeks, delivered through a secure teleconsultation with a DHA-licensed genetic counselor.
3. Who should consider this test?
Individuals with a personal or family history of bicuspid aortic valve, early-onset aortic stenosis or regurgitation, or those planning cardiac surgery benefit most. It is also recommended for first-degree relatives of a confirmed NOTCH1 mutation carrier to clarify lifelong risk and surveillance needs.
4. Is genetic counseling included after the test?
Yes, every report includes a telephonic consultation with a DHA-licensed physician who explains the clinical implications, cascade testing recommendations, and surveillance protocols tailored to your specific variant and family context.
UAE Regulatory & Data Privacy Adherence
- All personal health information is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health data handling complies with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ISO 9001:2015 Certified Facility – Cert: INT/EGQ/2509DA/3139.
Clinical & Logistical Metadata
| Test Name | NOTCH1 Gene Aortic Valve Disease Type 1 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) with Orthogonal Sanger Validation |
| ICD-10-CM Code | I35.0 (Nonrheumatic aortic valve stenosis), Q23.0 (Congenital stenosis of aortic valve) |
| LOINC Code | 21636-6 (Gene mutations detected in Blood or Tissue by Molecular genetics method Nominal) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians